Handol Kim – HCS21

Co-Founder & CEO, Variational AI

Handol is Co-Founder & CEO of Variational AI, an AI for drug discovery start-up based in Vancouver. Variational AI is applying its state-of-the-art generative AI to generate novel drug-like small molecules that are efficacious, safe, and synthesizable in months versus years. Handol brings over 20 years of executive management experience and leadership from venture-backed start-ups and publicly-listed technology companies in cloud, mobile/embedded, and telecommunications software in Silicon Valley, Canada, and Asia Pacific.

Handol serves on the boards of AI Network of British Columbia (AInBC), the Digital Technology Supercluster, and the United Way British Columbia.